Mandy G. Katz‐Jaffe

article 2024

PROLONGED ORAL GnRH ANTAGONIST ADMINISTRATION PRIOR TO EUPLOID EMBRYO TRANSFER (ET) IN ENDOMETRIOSIS (ENDO) PATIENTS: A PROSPECTIVE RANDOMIZED NON-INFERIORITY TRIAL

·doi:10.1016/j.fertnstert.2024.07.381

2021

Increased Systemic Antioxidant Power Ameliorates the Aging-Related Reduction in Oocyte Competence in Mice.

International journal of molecular sciences ·doi:10.3390/ijms222313019

Ovarian aging is associated with elevated oxidative stress and diminished oocyte developmental competence. We aimed to determine the impact of systemic antioxidant treatment in aged mice. Female outbred CF-1 mice were aged for 9 months prio…

article 2018

The impact of infertility diagnosis on embryo-endometrial dialogue

Reproduction (Cambridge, England) ·doi:10.1530/rep-17-0566

Abstract Initial stages of implantation involve bi-directional molecular crosstalk between the blastocyst and endometrium. This study investigated an association between infertility etiologies, specifically advanced maternal age (AMA) and e…

article 2017

GnRH agonist administration prior to embryo transfer in freeze-all cycles of patients with endometriosis or aberrant endometrial integrin expression

Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2017.05.004

Prolonged gonadotrophin-releasing hormone agonist (GnRHa) administration before IVF with fresh embryo transfer to patients with endometriosis or aberrant endometrial integrin expression (-integrin) improves outcomes but may suppress ovarian…

article 2016

Embryo-endometrial dialogue is altered in endometriosis patients through microRNA regulation

·doi:10.1016/j.fertnstert.2016.07.275

article 2016

Prolonged administration of GnRH agonist (GnRHa) prior to embryo transfer (ET) in endometriosis (ENDO) and integrin (INT)negative patients: the impact of freeze-all cycles

·doi:10.1016/j.fertnstert.2016.07.775